During the past decade, Heart and Vascular Center, Semmelweis University conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 3 clinical trials were completed, i.e. on average, 30% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Heart and Vascular Center, Semmelweis University" #1 sponsor was "Semmelweis University Heart and Vascular Center" with 8 trials, followed by "Abbott Medical Devices" with 2 trials sponsored, "Boston Scientific Corporation" with 2 trials sponsored, "Biosense Webster, Inc." with 1 trials sponsored and "InnovHeart" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Heart and Vascular Center, Semmelweis University" #1 collaborator was "Semmelweis University" with 2 trials as a collaborator, "Albany Stratton VA Medical Center" with 1 trials as a collaborator, "Bajcsy-Zsilinszky Hospital" with 1 trials as a collaborator, "Cedars-Sinai Medical Center" with 1 trials as a collaborator and "Columbia University" with 1 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Heart and Vascular Center, Semmelweis University" are "Coronary Artery Disease" (3 trials), "Myocardial Ischemia" (3 trials), "Cardiac Surgery" (2 trials), "Coronary Arteriosclerosis" (2 trials) and "Coronary Artery Restenosis" (2 trials). Many other conditions were trialed in "Heart and Vascular Center, Semmelweis University" in a lesser frequency.

Most popular intervention types in "Heart and Vascular Center, Semmelweis University" are "Device" (7 trials), "Procedure" (5 trials), "Drug" (4 trials), "Other" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "XIENCE V®/ XIENCE PRIME™" (2 trials), "ACP injections" (1 trials), "Acenocoumarol" (1 trials), "Blood test" (1 trials) and "COGNIS CRT-D" (1 trials). Other intervention names were less common.

The vast majority of trials in "Heart and Vascular Center, Semmelweis University" are 16 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Heart and Vascular Center, Semmelweis University". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 6 completed trials in Heart and Vascular Center, Semmelweis University, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Heart and Vascular Center, Semmelweis University, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 6 trials that are defined as “Not Applicable".